AXTI Surge Masks Persistent Permit Risk; Q2 Results Are the Real Test

What happened

AXT Inc. shares have surged 657% year-to-date, driven by booming AI optical-network demand for indium phosphide substrates, a record backlog, and plans to double capacity. However, the latest DeepValue report assigns a WAIT rating, cautioning that the market is pricing in smoother export-permit conversion than the company itself can predict. While Q1 2026 showed early improvement with $26.9M revenue and a 29.6% gross margin, the May 10-Q still states management “cannot predict” permit approval timing and has a backlog without permits. The critical test comes in Q2, where management guided for a record InP quarter above $17M—a miss here would undermine the entire growth thesis. Without systematic permit throughput, the equity-funded capacity expansion risks becoming a value-destroying dilution rather than a catalyst.

Implication

The bull case depends on two unproven variables: export-permit approvals becoming repeatable and capacity expansion executing on schedule. Even if Q2 meets expectations, the stock already prices a successful outcome. A miss or continued permit opacity would send shares sharply lower toward the $75 bear case. Wait for Q2 filings and conference call to gauge whether management’s optimistic tone aligns with hard evidence of improving permit flow. Only if filings show a disclosed permit cadence and North America revenue recovers above 5% should investors consider a position near the $90 attractive entry level.

Thesis delta

The dominant investment narrative has shifted from “AI optical demand drives growth” to “growth remains entirely gated by China export permits.” The market is pricing in a smooth permit conversion that the company itself admits is unpredictable, creating a disconnect that must be resolved by Q2 results. The core question is whether the Q1 permit improvements were a one-time event or the start of a systemic process.